Who has invested in Hugo Biotech?

Chuangxin Innovation Works, NLVC are named among the investors backing Hugo Biotech.

Hugo Biotech Funding: $34M Raised, Series A (2024)

Hugo Biotech funding overview

Hugo Biotech is based in Beijing, China. Hugo Biotech has raised $34M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2024. The round record for Hugo Biotech runs through 2024; nothing later has been disclosed. Investors on record include Chuangxin Innovation Works, NLVC. 2 distinct backers are named across the disclosed rounds.

Hugo Biotech at a glance

Total raised: $34M
Latest round: Series A
Latest round date: December 2024
Headquarters: Beijing, China
Notable investors: Chuangxin Innovation Works, NLVC

Frequently asked about Hugo Biotech funding

How much has Hugo Biotech raised?: Hugo Biotech has raised $34M in total disclosed funding across the rounds on record.
Who has invested in Hugo Biotech?: Chuangxin Innovation Works, NLVC are named among the investors backing Hugo Biotech.
What was the latest Hugo Biotech funding round?: The most recent disclosed round is a Series A, announced in December 2024.
Where is Hugo Biotech based?: Hugo Biotech is based in Beijing, China.
When did Hugo Biotech last raise?: The last disclosed Hugo Biotech round closed in December 2024 at Series A.

Round data for Hugo Biotech is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the companies in Beijing and backer lists below.

Hugo Biotech Funding: $34M Raised, Series A (2024)

Hugo Biotech funding overview

Hugo Biotech at a glance

Frequently asked about Hugo Biotech funding

Companies related to Hugo Biotech (18)

Browse related funding lists (5)